Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Inject Pharma Sweden AB
AB
In liquidation
Org 5590021464
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2015 · 11 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Inject Pharma Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2019: 0M
0M
2019
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
EBITDA
SEK millions
0M
-6M
-11M
-17M
-22M
2019: -1M
-1M
2019
2020: -1M (0% vs 2019)
-1M
0%
2020
2021: -8M (-700% vs 2020)
-8M
-700%
2021
2022: 0M (+100% vs 2021)
0M
2022
2023: -18M
-18M
2023
Income statement
SEK thousands
Item
2023
2022
2021
2020
2019
Revenue
0
0
15
0
0
Staff expenses
—
—
—
—
—
EBITDA
−18 377
−237
−7 890
−1 201
−938
Depreciation & amort.
−0
−88
−42
−91 266
−42
EBIT
−18 377
−325
−7 932
−92 467
−980
Net financials
—
—
−2
—
24
Profit before tax
−18 377
−325
−7 934
−92 467
−957
Tax
−0
−0
−0
−0
−0
Net profit
−18 377
−325
−7 934
−92 467
−957
Balance sheet
SEK thousands
Item
2023
2022
2021
2020
2019
Total assets
610
43
426
8 317
67 762
Equity
610
−12
313
−3 753
60 714
Long-term debt
0
0
0
0
0
Short-term debt
0
55
113
12 070
7 048
Total debt
—
55
113
12 070
7 048
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2019
2023
Equity ratio
100,0 %
This company
38,2 %
Market median
This company
Market median
162% above market
2019
2023
Return on equity
<−999 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2019
2023
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2019
2023
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2019
2023
Debt / equity
0,00×
This company
0,62×
Market median
This company
Market median
100% below market
2019
2023
Annual reports & filings
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
More on Inject Pharma Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
